论文部分内容阅读
目的分析埃索美拉唑与莫沙必利联用对反流性食管炎的影响。方法 94例反流性食管炎患者,随机分为治疗组和常规组,各47例。常规组采用埃索美拉唑治疗,治疗组给予埃索美拉唑与莫沙必利联用治疗。观察两组疗效。结果治疗组总有效率为95.74%(45/47),常规组为80.85%(38/47),治疗组明显优于常规组(P<0.05);两组不良反应比较差异无统计学意义(P>0.05)。结论在对反流性食管炎患者进行治疗的过程中,通过采用埃索美拉唑与莫沙必利联合治疗效果优于单纯的埃索美拉唑治疗,能够提升患者整体的治疗效果,同时患者安全性高,不良反应轻,临床中可推广使用。
Objective To analyze the effect of esomeprazole combined with mosapride on reflux esophagitis. Methods 94 cases of reflux esophagitis patients were randomly divided into treatment group and conventional group, 47 cases each. The conventional group was treated with esomeprazole, and the treatment group was treated with esomeprazole and mosapride. The two groups were observed. Results The total effective rate was 95.74% (45/47) in the treatment group and 80.85% (38/47) in the conventional group, and the treatment group was significantly better than the conventional group (P <0.05). There was no significant difference in adverse reactions between the two groups P> 0.05). Conclusions In the treatment of patients with reflux esophagitis, esomeprazole combined with mosapride is superior to esomeprazole alone in treatment of patients with reflux esophagitis, which can improve the overall treatment effect of patients, at the same time Patients with high safety, adverse reactions, clinical use can be promoted.